German Retail Distributors Stock News

If you are wondering whether adidas at €166.65 is a bargain or still priced for perfection, you are in the right place for a clear look at what the current share price really implies. The stock has seen a 0.4% decline over the last week, a 0.5% decline over the last month, a 0.4% decline year to date, and a 31.0% decline over the last year. The 3 year return sits at 15.6%, and the 5 year return at a 38.1% decline. Recent discussion around adidas has centered on how the brand is positioned in...

Earnings event puts E.ON (XTRA:EOAN) back in focus Attention on E.ON (XTRA:EOAN) has picked up as the 25 February 2026 earnings date approaches, following several revenue and EPS misses in 2025 and ongoing concerns around leverage and free cash flow. See our latest analysis for E.ON. E.ON's share price has recently shown mixed momentum, with a 10.39% 1 month share price return and a 2.31% year to date share price return. Its 1 year total shareholder return of 65.47% and 5 year total...

If you are wondering whether Mercedes-Benz Group is attractively priced right now, this breakdown will help you see how the current share price lines up against several valuation checks. The stock trades at €60.37, with returns of 19.2% over 1 year and 78.4% over 5 years, while shorter term moves have been softer with a 2.5% decline over 7 days and a 0.6% decline over 30 days and year to date. Recent headlines around Mercedes-Benz Group have focused on its position in the global premium auto...

Earlier this week, MTU Aero Engines AG issued new senior unsecured convertible bonds with a principal amount of €600 million, maturing in July 2033, bearing no interest, a 47.5% conversion premium and an accreted redemption price of 105%, to refinance its 2027 convertible bonds and support general corporate purposes. By using the new zero‑coupon 2033 convertible bonds to repurchase up to €500 million of 2027 bonds, MTU is reshaping its capital structure, extending debt maturities and...

TKMS AG & Co KGaA was recently added to Germany’s MDAX Index and is in talks to supply six Type 214 submarines with Air-Independent Propulsion to the Indian Navy, alongside a potential acquisition of German Naval Yards. The combination of a potential large-scale India submarine contract, index inclusion, and consolidation moves in Germany’s naval shipbuilding sector marks a meaningful shift in TKMS’s profile within the defence industry. We’ll now examine how the prospective India Type 214...

The UK government’s decision to delay permitting for the planned 3GW Dogger Bank South offshore wind project places RWE (XTRA:RWE) in the spotlight, as investors assess how extended approval timelines could affect future project execution. See our latest analysis for RWE. RWE’s €47.96 share price sits against a recent backdrop of strong short term momentum, with an 18.65% 90 day share price return and a much higher 76.10% 1 year total shareholder return, suggesting sentiment has been...

In recent days, Barclays’ Alice Jennings and Kepler Capital have reiterated positive analyst views on TeamViewer SE, while corporate insiders have increased their share purchases, signalling stronger internal confidence in the company’s prospects. At the same time, a voting rights notification from Norway’s Ministry of Finance highlights shifting institutional ownership, adding an extra layer of context to this upswing in insider optimism. Now we’ll explore how this upswing in insider share...

Hensoldt (XTRA:HAG) has attracted fresh attention after securing a large follow up contract for 104,000 Mikron night vision devices, as well as long term maintenance, for the Bundeswehr and Belgian armed forces. See our latest analysis for Hensoldt. That contract arrives after a strong run in the share price, with a 7 day share price return of 19.5% and 30 day share price return of 25.93%, even though the 90 day share price return shows a 13.13% decline. Over the longer term, total...

Merck KGaA (XTRA:MRK) is back in focus after mixed financial updates, with one quarter showing an 11.8% profit decline despite 5.3% net sales growth, and another highlighting 4.7% organic revenue growth and higher EBITDA. See our latest analysis for Merck KGaA. The recent mixed earnings messages seem to align with Merck KGaA’s price action, with a 10.3% 1 month share price return and a 10.5% 3 month share price return contrasting with a 1 year total shareholder return decline of 8.3%. This...

Key Insights Grand City Properties' estimated fair value is €13.03 based on 2 Stage Free Cash Flow to Equity Current...

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Ideally, a business will show two...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Key Insights Institutions' substantial holdings in SAF-Holland implies that they have significant influence over the...

Key Insights The projected fair value for RealTech is €1.30 based on 2 Stage Free Cash Flow to Equity RealTech's €1.07...

For us, stock picking is in large part the hunt for the truly magnificent stocks. Not every pick can be a winner, but...

When we invest, we're generally looking for stocks that outperform the market average. And in our experience, buying...

Carl Zeiss Meditec AG ( ETR:AFX ) is reducing its dividend from last year's comparable payment to €0.55 on the 31st of...

One simple way to benefit from the stock market is to buy an index fund. But if you pick the right individual stocks...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

While Eckert & Ziegler SE ( ETR:EUZ ) might not have the largest market cap around , it saw a decent share price growth...

Fluor Corporation has completed mechanical works on BASF’s Zhanjiang Verbund project in China, the company’s largest investment to date, after more than 75 million work hours without a Lost Time Injury. Once fully running, the Zhanjiang site is set to become BASF’s third-largest Verbund hub worldwide, reinforcing its footprint in China’s vast chemicals market. We’ll now examine how mechanical completion of the Zhanjiang Verbund site could influence BASF’s investment narrative and future...

Fresenius Medical Care (XTRA:FME) is back on investors’ radar after recent share price swings, with returns over the past 3 months and year both in negative territory despite a positive 3 year total return. See our latest analysis for Fresenius Medical Care. With the share price at €39.50 and a 90 day share price return decline of 15.05%, recent momentum looks weaker, even though the 3 year total shareholder return of 30.31% is still positive. If Fresenius Medical Care has you reassessing...

In early January 2026, Redcare Pharmacy NV reported that fourth-quarter 2025 group sales rose to €794 million from €675 million a year earlier, with full-year 2025 revenue reaching €2.90 billion versus €2.40 billion in 2024. This step-up in quarterly and annual sales underlines how Redcare Pharmacy is converting its expanding digital pharmacy footprint into materially higher revenue scale. Next, we’ll examine how this stronger revenue base, particularly the uplift to €2.90 billion in 2025...

Recent developments highlight Siemens Healthineers’ expanded focus on smart portable ultrasound, leveraging AI, wireless connectivity and miniaturized devices for use in home healthcare, telemedicine and diverse clinical settings. This push into smarter, more mobile imaging tools underlines how Siemens Healthineers is tying next‑generation diagnostics directly to care delivery outside traditional hospitals. We’ll now explore how this push into AI‑enabled portable ultrasound could reshape...